Koers Compass Biotechnologies, Inc. Other OTC
Aandelen
US20452Q1031
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 158K 144K |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 | Nettowinst (verlies) 2019 | - 0 | EV/omzet 2018 | - |
Nettoschuld 2018 | 516K 472K | Nettoschuld 2019 | 480K 439K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-2,59
x | K/w-verhouding 2019 |
-3,95
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Mathew Knowles
SAM | Sales & Marketing | - | 22-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,30% | 4,81 mld. | |
-31,08% | 3,6 mld. | |
-0,71% | 3,09 mld. | |
-24,32% | 2,62 mld. | |
-11,35% | 2,27 mld. | |
+34,19% | 1,82 mld. | |
+33,49% | 1,41 mld. | |
-15,07% | 1,38 mld. | |
+40,95% | 1,37 mld. |